Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Denali Capital Acquisition Corp. | 10%+ Owner | Class B Ordinary Shares | 1.43M | Aug 30, 2024 | Indirect | ||
Estrella Immunopharma, Inc. | Chief Financial Officer | Common Stock | 264K | Sep 29, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DECA | Denali Capital Acquisition Corp. | Aug 30, 2024 | 1 | $0 | 4 | Sep 16, 2024 | 10%+ Owner |
UPTD | Estrella Immunopharma, Inc. | Sep 29, 2023 | 0 | $0 | 3 | Oct 10, 2023 | Chief Financial Officer |
DECA | Denali Capital Acquisition Corp. | May 21, 2022 | 1 | $0 | 4 | May 24, 2022 | 10%+ Owner |
DECA | Denali Capital Acquisition Corp. | Apr 11, 2022 | 1 | $5.1M | 4 | Apr 13, 2022 | 10%+ Owner |
DECA | Denali Capital Acquisition Corp. | Apr 6, 2022 | 0 | $0 | 3 | Apr 6, 2022 | 10%+ Owner |